PA
ALPN

Perceptive Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

Perceptive Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-30,569
Closed -$274K – 209
2016
Q4 		$274K Hold
30,569
– – 0.02% 136
2016
Q3 		$994K Sell
30,569
-681
-2% -$16.6K 0.06% 98
2016
Q2 		$575K Hold
31,250
– – 0.04% 106
2016
Q1 		$521K Hold
31,250
– – 0.05% 118
2015
Q4 		$968K Hold
31,250
– – 0.07% 88
2015
Q3 		$1.62M Buy
+31,250
New +$2.05M 0.13% 87

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Perceptive Advisors's ALPN Position: Q1 2017 in Review

Perceptive Advisors sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2017, closing a stake of 30,569 shares — an estimated $274K sold.

Perceptive Advisors first reported a position in ALPN in Q3 2015 and held it in 6 quarters. The position peaked at $1.62M in Q3 2015. 28 funds tracked by Wall St. Rank hold ALPN as of Q1 2017.

  • Perceptive Advisors reported no remaining Alpine Immune Sciences Inc position as of Q1 2017 after selling out during the quarter.
  • Perceptive Advisors sold 30,569 Alpine Immune Sciences Inc shares in Q1 2017, an estimated $274K.
  • Perceptive Advisors first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 6 quarters.
  • Perceptive Advisors's Alpine Immune Sciences Inc position peaked at $1.62M in Q3 2015.
  • 28 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2017.

Based on Perceptive Advisors's 13F filing for Q1 2017, filed 15 May 2017.